Bladder cancer biomarker proteins

Jérôme Garin; Christophe Masselon; Antonia Vlahou; Bruno Domon; Elodie Duriez; Francois Radvanyi; Yves Allory; Nuria Marquez Cid; Magali Mirari Court; Riera Malatas; Aurélie Kamoun; Manousos Makrydakis; Ieronimos Zoidakis

Bladder cancer biomarker proteins

Jérôme Garin (Inventor), Christophe Masselon (Inventor), Antonia Vlahou (Inventor), Bruno Domon (Inventor), Elodie Duriez (Inventor), Francois Radvanyi (Inventor), Yves Allory (Inventor), Nuria Marquez Cid (Inventor), Magali Mirari Court (Inventor), Riera Malatas (Inventor), Aurélie Kamoun (Inventor), Manousos Makrydakis (Inventor), Ieronimos Zoidakis (Inventor)

Luxembourg Institute of Health

Research output: Patent

Abstract

The invention relates to a collection of signature peptides representing at least 10 proteins for use in cancer diagnosis and/or prognosis, to an artificial protein comprising signature peptides representing at least 10 proteins and to a nucleic acid construct encoding for such an artificial protein. The invention further relates to a collection of at least 10 proteins for use in cancer diagnosis and/or prognosis. Additionally, the invention relates to a method for cancer diagnosis and/or prognosis comprising the step of analyzing at least 10 proteins in a urine sample of a subject. Finally, the invention relates to an immunoassay product comprising antibodies for detecting at least 10 proteins.

Original language	English
IPC	WO 2017/109171
Publication status	Published - 29 Jun 2017

Cite this

@misc{4a845ce58467433bb3076c3da990b48a,

title = "Bladder cancer biomarker proteins",

abstract = "The invention relates to a collection of signature peptides representing at least 10 proteins for use in cancer diagnosis and/or prognosis, to an artificial protein comprising signature peptides representing at least 10 proteins and to a nucleic acid construct encoding for such an artificial protein. The invention further relates to a collection of at least 10 proteins for use in cancer diagnosis and/or prognosis. Additionally, the invention relates to a method for cancer diagnosis and/or prognosis comprising the step of analyzing at least 10 proteins in a urine sample of a subject. Finally, the invention relates to an immunoassay product comprising antibodies for detecting at least 10 proteins.",

author = "J{\'e}r{\^o}me Garin and Christophe Masselon and Antonia Vlahou and Bruno Domon and Elodie Duriez and Francois Radvanyi and Yves Allory and {Marquez Cid}, Nuria and {Mirari Court}, Magali and Riera Malatas and Aur{\'e}lie Kamoun and Manousos Makrydakis and Ieronimos Zoidakis",

year = "2017",

month = jun,

day = "29",

language = "English",

type = "Patent",

note = "WO 2017/109171",

}

TY - PAT

T1 - Bladder cancer biomarker proteins

AU - Garin, Jérôme

AU - Masselon, Christophe

AU - Vlahou, Antonia

AU - Domon, Bruno

AU - Duriez, Elodie

AU - Radvanyi, Francois

AU - Allory, Yves

AU - Marquez Cid, Nuria

AU - Mirari Court, Magali

AU - Malatas, Riera

AU - Kamoun, Aurélie

AU - Makrydakis, Manousos

AU - Zoidakis, Ieronimos

PY - 2017/6/29

Y1 - 2017/6/29

N2 - The invention relates to a collection of signature peptides representing at least 10 proteins for use in cancer diagnosis and/or prognosis, to an artificial protein comprising signature peptides representing at least 10 proteins and to a nucleic acid construct encoding for such an artificial protein. The invention further relates to a collection of at least 10 proteins for use in cancer diagnosis and/or prognosis. Additionally, the invention relates to a method for cancer diagnosis and/or prognosis comprising the step of analyzing at least 10 proteins in a urine sample of a subject. Finally, the invention relates to an immunoassay product comprising antibodies for detecting at least 10 proteins.

AB - The invention relates to a collection of signature peptides representing at least 10 proteins for use in cancer diagnosis and/or prognosis, to an artificial protein comprising signature peptides representing at least 10 proteins and to a nucleic acid construct encoding for such an artificial protein. The invention further relates to a collection of at least 10 proteins for use in cancer diagnosis and/or prognosis. Additionally, the invention relates to a method for cancer diagnosis and/or prognosis comprising the step of analyzing at least 10 proteins in a urine sample of a subject. Finally, the invention relates to an immunoassay product comprising antibodies for detecting at least 10 proteins.

M3 - Patent

ER -

Bladder cancer biomarker proteins

Abstract

Fingerprint

Cite this